A Study to Assess the Use of Artificial Intellignce to Predict Eye Treatment Changes in Adult Participants With Diabetic Macular Edema
NCT07604545 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 554
Last updated 2026-05-22
Summary
This study is to assess the use of Artificial intellignce (AI) to predict eye treatment changes in adult participants with diabetic macular edema (DME).
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-30
- Primary Completion
- 2027-03-31
- Completion
- 2027-03-31
More Related Trials
-
Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
NCT06423274 ·Status: NOT_YET_RECRUITING
-
Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening
NCT07404657 ·Status: NOT_YET_RECRUITING
-
Artificial Intelligence for Diagnosing Diabetic Retinopathy in Primary Care
NCT07236879 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Fundus Images
NCT04612868 ·Status: COMPLETED ·Phase: NA
-
OCT-angiography in Diabetic Patients
NCT02870803 ·Status: UNKNOWN
-
Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
NCT01168258 ·Status: TERMINATED
-
Biomarkers of Diabetic Retinopathy Progression
NCT01607190 ·Status: COMPLETED
-
Diabetic Retinopathy and Visual Function Study
NCT00001346 ·Status: COMPLETED
-
Multimodal Biomarkers in Prediction of Diabetic Retinopathy
NCT07098832 ·Status: NOT_YET_RECRUITING
-
Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening
NCT03911323 ·Status: UNKNOWN
-
iOCT for Patients With Diabetic Macular Edema
NCT03328715 ·Status: COMPLETED ·Phase: NA
-
Assessment of EyeArt Performance With Retinal Imaging Devices
NCT04302012 ·Status: COMPLETED
-
Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes
NCT07559292 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images
NCT05857943 ·Status: COMPLETED ·Phase: NA
-
Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence
NCT06721351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Adaptive Optics for Ophthalmic Technologies
NCT02826655 ·Status: TERMINATED ·Phase: NA
-
Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03078231 ·Status: COMPLETED
-
Home Monitoring of Diabetic Macular Edema
NCT05223569 ·Status: UNKNOWN ·Phase: NA
-
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
NCT07151001 ·Status: RECRUITING
-
Automated AI-based System for Early Diagnosis of Diabetic Retinopathy
NCT05324189 ·Status: UNKNOWN
-
Early Changes in OCT Biomarkers After the First Intravitreal Anti-VEGF Injection in Treatment-naïve DME
NCT06841250 ·Status: ENROLLING_BY_INVITATION
-
Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCT
NCT03765112 ·Status: UNKNOWN ·Phase: NA
-
Bangladesh PRODUCTIVity in Eyecare Trial
NCT05182580 ·Status: COMPLETED ·Phase: NA
-
OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits
NCT01875783 ·Status: COMPLETED ·Phase: NA